Modern Diagnostic & Research Centre
Modern Diagnostic & Research Centre (MDRC) share price was ₹59.30 at the 28 Oct 2026 close; market capitalisation ₹89.58 Cr; sector Healthcare. In the Mar 2026 quarter, revenue was ₹39.92 Cr and net profit was ₹2.08 Cr. Promoters held 72.95% of Modern Diagnostic & Research Centre in Sep 2026, up 0.10 percentage points from Mar 2026.
Key Fundamentals
SMEHealthcare ServicesHealthcarePrice-based figures as of 28 Oct 2026, 15:30 IST · TTM
Peer Comparison
Healthcare › Healthcare Service Provider
| ₹1,906.00 | 58.94 | 31,992 Cr | 12.75 | 0.26% | 20.06% | 25.67% | 2,996 Cr | 545 Cr | |
| ₹1,440.20 | 79.00 | 14,834 Cr | 15.50 | 0.14% | 18.07% | 19.22% | 879 Cr | 187 Cr | |
| ₹548.30 | 56.35 | 11,371 Cr | 7.57 | 0.91% | 12.54% | 15.73% | 1,733 Cr | 203 Cr | |
| ₹516.25 | 46.59 | 8,217 Cr | 16.03 | 2.84% | 27.79% | 33.84% | 894 Cr | 176 Cr | |
| ₹630.35 | 150.44 | 6,339 Cr | 5.68 | 0.00% | 6.88% | 13.46% | 1,079 Cr | 85 Cr | |
| ₹319.60 | 46.45 | 1,665 Cr | 6.80 | 0.16% | 12.90% | 14.70% | 329 Cr | 35 Cr | |
| ₹494.75 | 16.23 | 1,605 Cr | 1.64 | 0.40% | 10.35% | 10.64% | 862 Cr | 98 Cr | |
| — | — | 90 Cr | 1.53 | 0.00% | 8.97% | 11.22% | — | — | |
| Median 8 companies | ₹548.30 | 56.35 | 7,278 Cr | 7.19 | 0.21% | 12.72% | 15.22% | 894 Cr | 176 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100. How it works →
No Tapetide Score has been computed for this stock yet.
Key Insights
Strengths
1- Company has a good return on equity (ROE) track record: 3 Years ROE 31.0%
Weaknesses
2- Though the company is reporting repeated profits, it is not paying out dividend
- Tax rate seems low
Technical Indicators
Oscillators
Bullish
Overall
Bearish
Moving Averages
Bearish
Growth Rate
change over 1 year
change over 1 year
change over 1 year
change over 1 year Operating margin 12.73% · Mar 2026
Quarterly Results
| Particulars | Mar 2026 |
|---|---|
| Sales | 39.92 |
| Expenses | 34.84 |
| Operating Profit | 5.08 |
| OPM % | 12.73% |
| Other Income | 0.41 |
| Interest | 1.46 |
| Depreciation | 2.83 |
| PBT | 1.2 |
| Tax % | -73.33% |
| Net Profit | 2.08 |
| EPS (₹) | 1.38 |
Profit & Loss
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 60.21 | 56.28 | 67.13 | 77.95 | 83.11 |
| Expenses | 54.19 | 57.26 | 55.99 | 59.84 | 70.3 |
| Operating Profit | 6.02 | -0.98 | 11.14 | 18.11 | 12.81 |
| OPM % | 10% | -1.74% | 16.59% | 23.23% | 15.41% |
| Other Income | 0.35 | 0.32 | 1.46 | 0.86 | 1.03 |
| Interest | 1.57 | 1.41 | 1.81 | 1.91 | 2.66 |
| Depreciation | 3.66 | 3.87 | 3.92 | 4.19 | 5.19 |
| PBT | 1.14 | -5.94 | 6.87 | 12.87 | 5.99 |
| Tax % | 227.19% | -3.54% | 15.57% | 29.99% | 12.19% |
| Net Profit | -1.45 | -5.73 | 5.79 | 9.01 | 5.25 |
| EPS (₹) | -1.32 | -5.21 | 5.26 | 8.19 | 3.48 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 11 | 15.1 |
| Reserves | 10.7 | 4.96 | 10.76 | 9.77 | 43.45 |
| Borrowings | 20.4 | 15.31 | 20.46 | 22.09 | 37.1 |
| Other Liabilities | 16.6 | 15.27 | 17.26 | 21.71 | 22.95 |
| Total Liabilities | 48.7 | 36.54 | 49.48 | 64.57 | 119 |
| Fixed Assets | 24.31 | 23.67 | 27.04 | 30.65 | 48.09 |
| CWIP | 0.75 | 0 | 3.6 | 9.11 | 10.18 |
| Investments | 5.29 | 0.11 | 0.21 | 0.23 | 16.97 |
| Other Assets | 18.35 | 12.76 | 18.63 | 24.58 | 43.36 |
| Total Assets | 48.7 | 36.54 | 49.48 | 64.57 | 119 |
Cash Flow
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating | 3.64 | -0.12 | 7.93 | 13.9 | 3.82 |
| Investing | -5.2 | 2.11 | -11.03 | -13.31 | -40.29 |
| Financing | 4.5 | -6.47 | 3.36 | -0.22 | 45.08 |
| Net Cash Flow | 2.94 | -4.48 | 0.26 | 0.37 | 8.62 |
| Free Cash Flow | -1.49 | -3.27 | -3.04 | 0.58 | -19.88 |
| CFO/EBITDA | 52 | 12 | 60 | 98 | 36 |
Ratios
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debtor Days | 54.56 | 52.27 | 56.28 | 59.75 | 69.3 |
| Inventory Days | 25.9 | 40.62 | 61.45 | 95.47 | 120 |
| Days Payable | 172 | 171 | 177 | 160 | 196 |
| Cash Conversion Cycle | -91.92 | -77.94 | -59.39 | -5.06 | -7.55 |
| Working Capital Days | -43.95 | -58.82 | -34.74 | -37.79 | -41.68 |
| ROCE % | — | -17.24% | 32.75% | 39.37% | 12.48% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Modern Diagnostic & Research Centre insights
48 extracted metrics + investor summaries across FY22–FY26.
Documents
Frequently Asked Questions about Modern Diagnostic & Research Centre
What does Modern Diagnostic & Research Centre Ltd do?
Where is Modern Diagnostic & Research Centre Ltd (MDRC) listed?
Which sector does Modern Diagnostic & Research Centre Ltd belong to?
What is the market capitalisation of Modern Diagnostic & Research Centre Ltd?
What is the 52-week high and low of Modern Diagnostic & Research Centre Ltd?
What is the Return on Equity (ROE) of Modern Diagnostic & Research Centre Ltd?
Company Information
Incorporated in 1985, Modern Diagnostic & Research Centre Limited (MDRC) is a diagnostic chain in India, offering a comprehensive range of pathology and radiology services.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544673.md for Modern Diagnostic & Research Centre Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.